Brief: Cosmo Pharmaceuticals H1 Loss Of EUR 20.8 Million

Cosmo NV

30/07/2019 06:10

July 30 (Reuters) - Cosmo Pharmaceuticals NV  COPN.S :
    * H1 REVENUES EUR 21.5M VERSUS EUR 36.7M LAST YEAR,
    * H1 OPERATING LOSS EUR 17.2M VERSUS EUR 7.2M LAST YEAR.
    * H1 LOSS FOR PERIOD EUR 20.8M INCLUDING SHARE OF CASSIOPEA
LOSS
EUR 2.8M

Source text for Eikon:  ID:nTENwzvo2a 
Further company coverage:  COPN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))